Want to see PAYS full AI Analyst Report?
PAYS Stock Chart & Stats
$6.29
-$0.08(-2.93%)
At close: 4:00 PM EST
$6.29
-$0.08(-2.93%)
Day’s Range― - ―
52-Week Range$3.08 - $8.88
Previous CloseN/A
Volume99.02K
Average Volume (3M)597.78K
Market Cap
$490.85M
Enterprise Value$392.93M
Total Cash (Recent Filing)$20.55M
Total Debt (Recent Filing)$5.92M
Price to Earnings (P/E)46.9
Beta1.54
Next Earnings
Aug 11, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding55,905,773
10 Day Avg. Volume667,944
30 Day Avg. Volume597,784
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)5.78
Price to Sales (P/S)3.42
P/FCF Ratio5.47
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue4.30
Enterprise Value/Gross Profit7.80
Enterprise Value/Ebitda16.84
Forecast
1Y Price Target
$9.50Price Target Upside51.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.24
Revenue Forecast (FY)$108.55M
Bulls Say, Bears Say
Bulls Say
Robust Free Cash FlowSustained high free cash flow and FCF-to-income parity indicate durable cash conversion from core operations. This strengthens financial flexibility for reinvestment, M&A or share actions, and reduces refinancing risk, supporting multi‑quarter growth and resilience to cyclical swings.
Profitability Inflection & MarginsA clear multi‑year shift to positive net and operating margins shows scalable unit economics and operating leverage. Higher margins improve cash generation, create buffer for reinvestment, and make growth more sustainable across the next several quarters even if revenue mix shifts.
Pharma/Patient Affordability MomentumRapidly expanding pharma program revenue and a growing pipeline indicate durable, higher‑margin recurring streams. Deeper program penetration and strong deal activity can drive steady revenue growth and improve retention over the medium term, reducing reliance on volatile segments.
Bears Say
SaaS/App Not Revenue-GeneratingPlanned SaaS monetization remains uncertain and timing is unclear due to regulatory engagement. Delay in revenue realization from this product means anticipated diversification and higher‑margin revenue may not materialize within the 2–6 month horizon, keeping execution risk elevated.
Plasma Center Concentration & ClosuresCustomer actions reducing center counts highlight concentration and operational fragility in the plasma channel. Losses or closures by key clients can materially affect volumes and cash receipts, making revenue and cash projections more sensitive to a few counterparties over coming quarters.
Large Asset Base Vs Equity SensitivityA sizable asset base relative to equity signals reliance on large balance‑sheet accounts (customer deposits/restricted cash). This can amplify earnings and cash flow volatility if operational flows change, increasing the importance of tight liquidity and working‑capital management going forward.
PaySign News
PAYS FAQ
What was PaySign Inc Class B’s price range in the past 12 months?
PaySign Inc Class B lowest stock price was $3.08 and its highest was $8.88 in the past 12 months.
What is PaySign Inc Class B’s market cap?
PaySign Inc Class B’s market cap is $490.85M.
When is PaySign Inc Class B’s upcoming earnings report date?
PaySign Inc Class B’s upcoming earnings report date is Aug 11, 2026 which is in 31 days.
How were PaySign Inc Class B’s earnings last quarter?
PaySign Inc Class B released its earnings results on May 12, 2026. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.02.
Is PaySign Inc Class B overvalued?
According to Wall Street analysts PaySign Inc Class B’s price is currently Undervalued.
Does PaySign Inc Class B pay dividends?
PaySign Inc Class B does not currently pay dividends.
What is PaySign Inc Class B’s EPS estimate?
PaySign Inc Class B’s EPS estimate is 0.06.
How many shares outstanding does PaySign Inc Class B have?
PaySign Inc Class B has 55,905,773 shares outstanding.
What happened to PaySign Inc Class B’s price movement after its last earnings report?
PaySign Inc Class B reported an EPS of $0.09 in its last earnings report, beating expectations of $0.07. Following the earnings report the stock price went down -12.331%.
Which hedge fund is a major shareholder of PaySign Inc Class B?
Currently, no hedge funds are holding shares in PAYS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
PaySign Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.50 (51.03% Upside)
$9.50 (51.03% Upside)
Blogger Sentiment
Neutral
PAYS Sentiment 50%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 3.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 23.5%
Last 30 Days ▲ 23.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.29%
12-Months-Change
Fundamentals
Return on Equity
21.74%
Trailing 12-Months
Asset Growth
52.46%
Trailing 12-Months
Company Description
PaySign Inc Class B
Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. The company offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card and software solutions. It also operates a customer service center; and offers a communication suite, including mobile app, two-way SMS, text alerts, and cardholder web portal. The company markets its prepaid card solutions under the Paysign brand. It serves companies and municipalities that require payment solutions for rewards, rebates, payment assistance, and other payments to their customers, employees, agents, and others. Paysign, Inc. was founded in 2001 and is headquartered in Henderson, Nevada.
PAYS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted a very strong quarter: substantial revenue and profit growth, wide margin expansion, a robust pharma pipeline, and continued plasma revenue expansion and cash generation. Management reiterated confident full-year guidance and plans to exceed prior program-addition performance. Key risks discussed include a lower-than-guided plasma center count (due to sales/closures), the SaaS/app not yet producing revenue (FDA engagement ongoing), a higher effective tax rate, and margin variability driven by seasonal mix. Overall the positives (large percentage growth across revenue, EBITDA, operating margin, patient assistance dollars, and pipeline strength) substantially outweigh the operational and timing-related lowlights.View all PAYS earnings summariesPAYS Stock 12 Month Forecast
Average Price Target
$9.50
▲(51.03% Upside)
Technical Analysis
International Money Express
―
Repay Holdings
―
AvePoint
―
Payoneer
―
Bakkt Holdings, Inc. Class A
―
Ownership Overview
19.32% Insiders
7.42% Mutual Funds
0.19% Other Institutional Investors
64.58% Public Companies and Individual Investors